Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast CancerSilvia Martini, Valentina Zuco, Monica Tortoreto, et al.
Cancers|June 10, 2020
SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage RepairRihan El Bezawy, Martina Tripari, Stefano Percio, et al.
Nature Communications|January 20, 2019
LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiationValentina Profumo, Barbara Forte, Stefano Percio, et al.
Cancer Gene Therapy|March 30, 2022
miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesotheliomaRihan El Bezawy, Stefano Percio, Chiara Maura Ciniselli, et al.
Disease Models & Mechanisms|May 9, 2023
Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograftValentina Zuco, Sandro Pasquali, Monica Tortoreto, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 2, 2021
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down-regulationValentina Zuco, Sandro Pasquali, Monica Tortoreto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2025
CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)Dario Callegaro, Gabriele Tinè, Felix Boakye Oppong, et al.
European Journal of Cancer (Oxford, England : 1990)|November 14, 2024
Radiomic features of primary retroperitoneal sarcomas: a prognostic studySandro Pasquali, Sara Iadecola, Andrea Vanzulli, et al.
Cancers|July 24, 2019
Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived XenograftSilvia Stacchiotti, Valentina Zuco, Monica Tortoreto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2024
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 SuppressionSilvia Stacchiotti, Silvia Martini, Sandro Pasquali, et al.
Pageof 3